(Q43010842)

12 November 2017

0 references

Molecular response of gastrointestinal stromal tumour after treatment with tyrosine kinase inhibitor imatinib mesylate (English)

1 reference

12 November 2017

1 reference

Reichardt P

1

1 reference

12 November 2017

Schneider U

2

1 reference

12 November 2017

Stroszczynski C

3

1 reference

12 November 2017

Pink D

4

1 reference

12 November 2017

Hohenberger P

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Journal of Clinical Pathology

12 November 2017

1 reference

12 November 2017

57

1 reference

12 November 2017

2

1 reference

12 November 2017

215-217

1 reference

Management of malignant gastrointestinal stromal tumours

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Gastrointestinal stromal tumors: recent advances in understanding of their biology

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Morphology of gastrointestinal stromal tumors in advanced stages of the disease: baseline findings before chemotherapy with imatinib

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770203

Gastric stromal sarcomas: correlation of MR imaging and histopathologic findings in nine patients

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14747457

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.2004.11379

1 reference

12 November 2017

1 reference

12 November 2017

1 reference